
Sign up to save your podcasts
Or
This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting, the CONTACT03 Trial. We also cover subgroup analysis interpretation.
4.8
168168 ratings
This week’s episode is part 3 of 5 of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of metastatic renal cell carcinoma (mRCC) and covering an oral abstract from the ASCO 2023 annual meeting, the CONTACT03 Trial. We also cover subgroup analysis interpretation.
323 Listeners
496 Listeners
58 Listeners
274 Listeners
3,318 Listeners
1,084 Listeners
194 Listeners
43 Listeners
513 Listeners
351 Listeners
244 Listeners
109 Listeners
53 Listeners
363 Listeners
38 Listeners